ESR (Erythrocyte Sedimentation Rate)
One of the oldest laboratory tests — simple, cheap, and still useful in select situations, though in most cases it's been replaced by the faster and more specific CRP.
Number of studies
1
Safety
Requires caution
Time to effects
Not applicable — ESR is a diagnostic test, not an intervention.
Who it's for
Table of contents
TL;DR
One of the oldest laboratory tests — simple, cheap, and still useful in select situations, though in most cases it's been replaced by the faster and more specific CRP.
- →Remains a valuable, well-validated tool for diagnosing and monitoring giant cell arteritis and polymyalgia rheumatica
- →A simple, cheap, and widely available test even in basic laboratories
- →An extremely elevated result (above roughly 100 mm/h) correlates strongly with a serious underlying condition, most often infection, autoimmune disease, or cancer
| Test type | Measures how fast red blood cells settle in a tube over one hour, a nonspecific inflammation marker |
|---|---|
| Level of evidence | Strong for select uses (e.g., monitoring giant cell arteritis), limited as a general screening test |
| Target group | People with suspected rheumatic disease, chronic inflammation, or unexplained general symptoms |
| Key parameter | ESR result in mm/h, strongly dependent on age and sex — reference ranges rise with age |
| Preparation | Doesn't require fasting; the result depends on sample quality and how quickly it reaches the lab |
| Status | A historical test, largely supplanted by CRP, but still useful for select rheumatologic indications |
Understand
Overview
The erythrocyte sedimentation rate (ESR), known in Poland as odczyn Biernackiego (OB) after the Polish physician who described it in the early 20th century, measures how far red blood cells settle in a vertical tube of anticoagulated blood over one hour — the faster they settle, the higher the ESR, which indirectly signals a more active inflammatory process in the body.
ESR is a nonspecific test — an elevated result doesn't point to a particular disease, only signals the presence of inflammation, infection, an autoimmune condition, or, less often, cancer. In recent decades, ESR has largely been supplanted by C-reactive protein (CRP) as the first-choice inflammation marker, since CRP responds faster (within hours rather than days) and is less prone to distortion by factors unrelated to inflammation, such as age or anemia.
Who can genuinely benefit from this? ESR retains particular clinical value in the diagnosis and monitoring of select rheumatic conditions, especially giant cell arteritis (temporal arteritis) and polymyalgia rheumatica, where extremely elevated values (often above 100 mm/h) carry real diagnostic significance. Outside these indications, ESR is still sometimes ordered as a cheap, general screening test, though its value in that role is limited.
Mechanism of action
How fast red blood cells settle depends mainly on the concentration of plasma proteins, especially fibrinogen and immunoglobulins — acute-phase proteins whose liver production rises under the influence of pro-inflammatory cytokines (mainly interleukin-6) released in response to infection, tissue injury, or an autoimmune process. Elevated levels of these proteins neutralize the negative surface charge of red blood cells that, under normal conditions, causes them to repel one another — red blood cells begin clumping into so-called rouleaux, which settle faster than individual cells, raising the ESR result.
Because the change in fibrinogen and other acute-phase proteins in response to inflammation unfolds gradually, over several days, ESR responds more slowly than CRP both to the onset and to the resolution of an inflammatory process — which can be misleading with a rapidly changing clinical picture. On top of that, factors unrelated to inflammation itself affect the ESR result: anemia and macrocytosis raise it (fewer, larger red blood cells favor rouleaux formation), while polycythemia, microcytosis, and extreme leukocytosis lower it, further limiting the test's specificity.
Rise in acute-phase proteins
Pro-inflammatory cytokines (mainly IL-6) drive the liver to produce more fibrinogen and immunoglobulins.
Neutralization of red blood cell charge
Elevated levels of these proteins weaken the natural repulsion between red blood cells, favoring clumping.
Rouleaux formation and faster settling
Red blood cells clumped into rouleaux settle faster than individual cells, raising the ESR result.
Evidence: strong — based on 1 study in this database.
Benefits
Common myths
MythA normal ESR result rules out a significant inflammatory or malignant condition.
FactAs a standalone screening test, ESR has limited sensitivity — a normal result doesn't rule out serious disease, especially early on, before acute-phase protein levels have had time to rise.
MythESR and CRP measure exactly the same thing and can be used interchangeably.
FactBoth are nonspecific inflammation markers, but CRP responds faster (hours) and is less affected by factors unrelated to inflammation than ESR, which responds more slowly (days) and also depends on age, sex, or anemia.
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
Both are nonspecific markers of inflammation, but CRP responds much faster (within hours) and is less affected by factors unrelated to inflammation, while ESR responds more slowly (within days) and depends more strongly on age, sex, or anemia.
Values above roughly 100 mm/h are considered extremely elevated and correlate strongly with a serious underlying condition — most often infection, autoimmune disease (e.g., giant cell arteritis), or cancer, though final interpretation always requires clinical assessment.
Its value as a general screening test in people without symptoms is limited and not supported by the literature — but it retains real value for specific indications, especially diagnosing and monitoring giant cell arteritis and polymyalgia rheumatica.
What to combine with
Good combinations
CRP and hs-CRP — CRP responds faster than ESR and helps confirm or refine the picture of how inflammation is changing over time
Complete Blood Count (CBC) — A complete blood count helps rule out anemia or red blood cell abnormalities that can artificially raise or lower the ESR result
Safety
Side effects & contraindications
Possible side effects
Contraindications
No significant contraindications at typical doses.
Interactions
Anemia and macrocytosis raise ESR independent of any actual inflammation
Pregnancy, obesity, older age, and being female physiologically raise ESR — reference ranges increase with age and are higher in women
Polycythemia, extreme leukocytosis, and certain red blood cell shape disorders (e.g., spherocytosis, sickle cell anemia) can artificially lower the result
Is it worth taking?
Who it's for
- People with suspected giant cell arteritis or polymyalgia rheumatica, where ESR has well-established diagnostic and monitoring value
- People with unexplained general symptoms (chronic fatigue, low-grade fevers, weight loss) as part of a broader differential workup
Not for
- No significant contraindications at typical doses.
Evidence
Worth knowing
ESR reference ranges rise with age and are typically higher in women than men — a rough rule of thumb is age/2 for men and (age+10)/2 for women.
The test was described in the early 20th century by Polish physician Edmund Biernacki, hence its Polish name odczyn Biernackiego, while English-language literature uses the term ESR.
Studies
ESR remains useful in specific diagnosis of giant cell arteritis, polymyalgia rheumatica, and probably rheumatoid arthritis, and in monitoring these conditions, while the literature does not support its usefulness as a general screening test for detecting serious disease.
Brigden ML, American Family Physician, 1999
Clinical utility of the erythrocyte sedimentation rate
Strong evidenceBrigden ML · American Family Physician · 1999
A classic clinical review examining the real diagnostic value of ESR, including the indications where it retains usefulness and the limitations of its use as a screening test.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Anna KowalczykEditor-in-Chief, Molecular Biology
Anna studied molecular biology at the University of Warsaw, then spent eight years after her PhD in a lab researching the mechanisms of cellular aging and autophagy. She stumbled into science journalism almost by accident — frustrated by how easily her field's findings get oversimplified in the media, she started a blog explaining the biology of aging in plain language. That blog became the seed of VitMode. Today Anna oversees the entire editorial process, holding every piece to the same rigor her old lab demanded: primary sources, methodology checks, and honesty about the limits of the evidence. Outside work, she's a dedicated boulderer.
148 publications on this site
Medical review
dr Piotr ZielińskiEndocrinologist
Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.
199 publications on this site
Related entries
4.5CRP and hs-CRP
A protein produced by the liver in response to inflammation — in its high-sensitivity form (hs-CRP) it has become one of the most widely studied additional markers of cardiovascular risk.
4.6Complete Blood Count (CBC)
The most commonly ordered laboratory test in the world — a seemingly simple printout hides information about immunity, oxygen transport, and blood clotting, if you know what to look for.
4.5How to Read a Basic Blood Test Panel
CBC, lipid panel, glucose, TSH — how to read the results of a basic blood panel so you catch early signals of a problem before it becomes a disease.
4.7Liver Panel (ALT, AST, GGT, Bilirubin)
Four entries on a lab printout — ALT, AST, GGT, and bilirubin — can reveal liver damage before any symptoms appear, as long as you know how to tell a hepatocellular pattern apart from a cholestatic one.
4.7Creatinine and eGFR (Estimated Glomerular Filtration Rate)
Creatinine alone tells you surprisingly little about kidney function — only converting it into eGFR using the CKD-EPI equation reveals how much filtration capacity actually remains.
4.7TSH and Thyroid Hormones (fT3, fT4, anti-TPO)
TSH is the first-line test for evaluating thyroid function, but on its own it rarely gives the full picture — only together with fT4, fT3, and anti-TPO can it distinguish a temporary fluctuation from an actual disorder.
4.6Electrolytes: Sodium, Potassium, and Chloride
Sodium, potassium, and chloride sound like a chemistry-class topic, but their blood levels determine how your heart, muscles, and kidneys function — and even a small deviation can be an urgent warning sign.
4.6Uric Acid (Blood Test)
Uric acid is the end product of purine breakdown — its blood test helps assess the risk of gout and kidney stones, but a single result on its own neither confirms nor rules out disease.
Related articles
PoradnikiNormal Testosterone, But You Feel Awful — Could You Still Have Hypogonadism?
A testosterone result that comes back "in range" on a lab printout doesn't always mean everything is hormonally fine — but it doesn't automatically mean you have hypogonadism either. We explain four real explanations for this mismatch, ranked by strength of evidence.
August 15, 2026
PoradnikiTRT or Natural Testosterone Boosting? A Practical Decision Test Before You Pick a Path
Before weighing the merits of TRT against the merits of lifestyle change, work out which of four situations you're actually in — because that, not preference or opinions from the internet, is what should decide your path.
August 15, 2026
PoradnikiTRT and High Estradiol — Symptoms, Causes, and What You Can Do About It
Suspect you have high estradiol on TRT? Before you reach for a forum post and someone else's anastrozole protocol, check which symptoms actually point to it and what order to act in — from bloodwork, through talking to your doctor, to a possible medication.
August 15, 2026
PoradnikiThe Most Common TRT Mistakes — 15 Things That Can Undermine Your Therapy's Results
A wrap-up of our entire testosterone therapy series: fifteen common, real mistakes — from diagnostics to discontinuation — that can turn a well-designed TRT protocol into a source of disappointment or genuine health risk.
August 15, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.